Simplex Trading’s Evogene EVGN Stock Holding History

Simplex Trading’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-240	Closed	-$1K	–	10158
2022 Q2	$1K	Sell	240 -430	-64%	-$4.2K	﹤0.01%	9564
2022 Q1	$8K	Sell	670 -200	-23%	-$2.7K	﹤0.01%	9049
2021 Q4	$14K	Sell	870 -2,190	-72%	-$49.7K	﹤0.01%	8737
2021 Q3	$102K	Hold	3,060	–	–	﹤0.01%	6593
2021 Q2	$104K	Buy	3,060 +3,046	+21,757%	+$119K	﹤0.01%	6672
2021 Q1	$69K	Buy	+14	New	+$866	﹤0.01%	6229

Other funds holding EVGN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RIG

Renaissance Investment Group Lenox, Massachusetts $508M AUM 30.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Simplex Trading's EVGN Position: Q3 2024 in Review

Simplex Trading sold out of Evogene (EVGN) in Q3 2024, closing a stake of 117 shares.

Simplex Trading first reported a position in EVGN in Q1 2021 and held it in 13 quarters. The position peaked at $92K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

Simplex Trading reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
Simplex Trading sold 117 Evogene shares in Q3 2024.
Simplex Trading first reported a position in Evogene in Q1 2021 and held it in 13 quarters.
Simplex Trading's Evogene position peaked at $92K in Q1 2021.
14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.